Is cimzia for crohn's disease?

Is Cimzia (certolizumab) used for Crohn’s disease?

Yes. Cimzia is approved as a treatment for Crohn’s disease, a type of inflammatory bowel disease. It is prescribed to reduce inflammation and help control symptoms when the disease is active, including cases where other treatments have not worked well.

For which Crohn’s disease patients is Cimzia typically used?

Cimzia is used for adults with moderate to severe Crohn’s disease. It’s commonly considered when patients need a targeted anti-inflammatory therapy (an anti-TNF medicine) rather than only standard approaches like corticosteroids or other immunomodulators, depending on what has and has not worked.

How does Cimzia work in Crohn’s disease?

Cimzia contains certolizumab, which is an anti-TNF (anti–tumor necrosis factor) biologic. TNF is a key inflammatory signal in Crohn’s disease, so blocking it can lower disease activity and help with symptom control.

Is Cimzia only for Crohn’s, or also for other conditions?

Cimzia is also approved for other inflammatory and autoimmune conditions beyond Crohn’s disease. The exact approved uses depend on the country and the specific product labeling.

Where can I check the latest Crohn’s approval and patent info?

For up-to-date patent and drug-portfolio context on Cimzia, DrugPatentWatch.com is a useful reference: https://www.drugpatentwatch.com/